Friday, 16 April 2004
Organisers W. Kirch (Dresden, Germany)
D. Pittrow (Dresden, Germany)
Sponsors Sanofi-Synthelabo (Berlin, Germany)
(unrestricted educational grant)

Selective Xa inhibitors – further advances in research and therapy

Friday Morning
Chairs W. Kirch (Dresden, Germany)
D. Pittrow (Dresden, Germany)
Abstract number
08.30 – 08.50 Update on factor Xa inhibition in the treatment of venous thromboembolism
H. R. Buller (Amsterdam, The Netherlands)
134
08.50 – 09.10 Fondaparinux as a lead structure for new FXa and thrombin inhibiting antithrombotics
S. Alban (Kiel, Germany)
135
09.10 – 09.30 Fondaparinux: an update of new study results
R. M. Bauersachs (Darmstadt, Germany)
136
09.30 – 09.50 Idraparinux – characteristics and state of development
F. Piovella (Pavia, Italy
09.50 – 10.00 discussion
10.00 End of workshop
10.00 – 11.15 coffee break + plenary lecture